CENTRE HOSPITALIER UNIVERSITAIRE DE DIJON
🇫🇷France
SOcioeconomics Status and Post-Intensive Care Syndrome
Not yet recruiting
- Conditions
- Post Intensive Care Syndrome (PICS)
- First Posted Date
- 2024-11-20
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Centre Hospitalier Universitaire Dijon
- Target Recruit Count
- 180
- Registration Number
- NCT06697236
- Locations
- 🇫🇷
CHU Dijon Bourgogne, Dijon, France
The Value of Measuring Retinal Vascular Density by Optical Coherence Tomography-Angiography (OCT-A) in Patients with Microvascular Angina Confirmed by Myocardial Microcirculatory Resistance Index (MRI).
Recruiting
- Conditions
- Microvascular Angina
- Interventions
- Biological: Blood samplingProcedure: Ophthalmological examinationOther: angina severity questionnaire
- First Posted Date
- 2024-11-18
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Centre Hospitalier Universitaire Dijon
- Target Recruit Count
- 158
- Registration Number
- NCT06692751
- Locations
- 🇫🇷
CHU Dijon Bourgogne, Dijon, France
Evaluation of the Impact of Psychological Profile on Diabetic Foot Wound Healing. Prospective, Monocentric Study
Recruiting
- Conditions
- Foot WoundType 2 Diabetes
- First Posted Date
- 2024-10-08
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- Centre Hospitalier Universitaire Dijon
- Target Recruit Count
- 308
- Registration Number
- NCT06630182
- Locations
- 🇫🇷
CHU Dijon Bourgogne, Dijon, France
Retinal Microvascularization in OCT-angiography and Systemic Diseases
Recruiting
- Conditions
- Systemic Vascular Damage
- Interventions
- Other: Retinal imagingBiological: Biological check-up
- First Posted Date
- 2024-09-26
- Last Posted Date
- 2024-09-26
- Lead Sponsor
- Centre Hospitalier Universitaire Dijon
- Target Recruit Count
- 5000
- Registration Number
- NCT06613555
- Locations
- 🇫🇷
Chu Dijon Bourogne, Dijon, France
Pilot Study to EvaluateThrombomodulin to Rule Out Giant Cell Arteritis (GCA) in Polymyalgia Rheumatica (PMR) Patients. (THROPIQ)
Recruiting
- Conditions
- Giant Cell Arteritis (GCA)Polymyalgia Rheumatica (PMR)
- Interventions
- Biological: Additional blood samples
- First Posted Date
- 2024-09-24
- Last Posted Date
- 2025-01-07
- Lead Sponsor
- Centre Hospitalier Universitaire Dijon
- Target Recruit Count
- 75
- Registration Number
- NCT06609668
- Locations
- 🇫🇷
CHU Dijon Bourgogne, Dijon, France
Influence of Olfacto-gustatory Sensoriality on the Nutritional Status of Patients with Amyotrophic Lateral Sclerosis
Not yet recruiting
- Conditions
- Amyotrophic Lateral Sclerosis (ALS)
- First Posted Date
- 2024-09-23
- Last Posted Date
- 2024-09-23
- Lead Sponsor
- Centre Hospitalier Universitaire Dijon
- Target Recruit Count
- 60
- Registration Number
- NCT06608004
- Locations
- 🇫🇷
Chu Dijon Bourgogne, Dijon, France
Evaluation of the Effectiveness of Intensive Medical Follow-up with an Advanced Practice Nurse Compared with Medical Follow-up Alone in Non-severe Pulmonary Embolism.
Not Applicable
Recruiting
- Conditions
- Non-severe Pulmonary Embolism
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Centre Hospitalier Universitaire Dijon
- Target Recruit Count
- 360
- Registration Number
- NCT06598930
- Locations
- 🇫🇷
Chu Dijon Bourgogne, Dijon, France
Oncology, Undernutrition and Sensoriality: Links, Mechanisms and Levers for Action
Recruiting
- Conditions
- Newly Diagnosed Cancer of the Oropharynx, Oral Cavity, Colon or Liver
- Interventions
- Other: tests/questionnairesBiological: biological samplesOther: evaluation
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-09-19
- Lead Sponsor
- Centre Hospitalier Universitaire Dijon
- Target Recruit Count
- 306
- Registration Number
- NCT06600295
- Locations
- 🇫🇷
Chu Dijon Bourgogne, Dijon, France
Walking ANalysis Interest in Persons wiTh facioscapulohumEral Muscular Dystrophies
Not Applicable
Recruiting
- Conditions
- Facioscapulohumeral Dystrophy
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- Centre Hospitalier Universitaire Dijon
- Target Recruit Count
- 60
- Registration Number
- NCT06600308
- Locations
- 🇫🇷
Chu Dijon Bourgogne, Dijon, France
Assess the Efficacy of OM-89 vs Placebo in Reducing Antibiotic Consumption Associated With the Treatment of Urinary Tract Infections in Patients With Neurogenic Bladder
Phase 3
Recruiting
- Conditions
- Neurogenic Bladder
- Interventions
- Drug: OM-89 [Uro-Vaxom® Capsule] OM-89 placebo [Uro-Vaxom® Capsule placebo]Drug: OM-89 [Uro-Vaxom® Capsule]
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-12-30
- Lead Sponsor
- Centre Hospitalier Universitaire Dijon
- Target Recruit Count
- 110
- Registration Number
- NCT06588010
- Locations
- 🇫🇷
CHU Dijon Bourgogne, Dijon, France